← Evidence map

ArticleCancer chemotherapy and pharmacology2016

Understanding the role of tariquidar, a potent Pgp inhibitor, in combination trials with cytotoxic drugs: What is missing?

Nuggehally R SrinivasPubMed ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27178178